TY - JOUR A1 - Peindl, Matthias A1 - Göttlich, Claudia A1 - Crouch, Samantha A1 - Hoff, Niklas A1 - Lüttgens, Tamara A1 - Schmitt, Franziska A1 - Pereira, Jesús Guillermo Nieves A1 - May, Celina A1 - Schliermann, Anna A1 - Kronenthaler, Corinna A1 - Cheufou, Danjouma A1 - Reu-Hofer, Simone A1 - Rosenwald, Andreas A1 - Weigl, Elena A1 - Walles, Thorsten A1 - Schüler, Julia A1 - Dandekar, Thomas A1 - Nietzer, Sarah A1 - Dandekar, Gudrun T1 - EMT, stemness, and drug resistance in biological context: a 3D tumor tissue/in silico platform for analysis of combinatorial treatment in NSCLC with aggressive KRAS-biomarker signatures JF - Cancers N2 - Epithelial-to-mesenchymal transition (EMT) is discussed to be centrally involved in invasion, stemness, and drug resistance. Experimental models to evaluate this process in its biological complexity are limited. To shed light on EMT impact and test drug response more reliably, we use a lung tumor test system based on a decellularized intestinal matrix showing more in vivo-like proliferation levels and enhanced expression of clinical markers and carcinogenesis-related genes. In our models, we found evidence for a correlation of EMT with drug resistance in primary and secondary resistant cells harboring KRAS\(^{G12C}\) or EGFR mutations, which was simulated in silico based on an optimized signaling network topology. Notably, drug resistance did not correlate with EMT status in KRAS-mutated patient-derived xenograft (PDX) cell lines, and drug efficacy was not affected by EMT induction via TGF-β. To investigate further determinants of drug response, we tested several drugs in combination with a KRAS\(^{G12C}\) inhibitor in KRAS\(^{G12C}\) mutant HCC44 models, which, besides EMT, display mutations in P53, LKB1, KEAP1, and high c-MYC expression. We identified an aurora-kinase A (AURKA) inhibitor as the most promising candidate. In our network, AURKA is a centrally linked hub to EMT, proliferation, apoptosis, LKB1, and c-MYC. This exemplifies our systemic analysis approach for clinical translation of biomarker signatures. KW - EMT KW - drug resistance KW - invasion KW - stemness KW - 3D lung tumor tissue models KW - KRAS biomarker signatures KW - boolean in silico models KW - targeted combination therapy Y1 - 2022 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-270744 SN - 2072-6694 VL - 14 IS - 9 ER - TY - JOUR A1 - Alzheimer, Mona A1 - Svensson, Sarah L. A1 - König, Fabian A1 - Schweinlin, Matthias A1 - Metzger, Marco A1 - Walles, Heike A1 - Sharma, Cynthia M. T1 - A three-dimensional intestinal tissue model reveals factors and small regulatory RNAs important for colonization with Campylobacter jejuni JF - PLoS Pathogens N2 - The Gram-negative Epsilonproteobacterium Campylobacter jejuni is currently the most prevalent bacterial foodborne pathogen. Like for many other human pathogens, infection studies with C. jejuni mainly employ artificial animal or cell culture models that can be limited in their ability to reflect the in-vivo environment within the human host. Here, we report the development and application of a human three-dimensional (3D) infection model based on tissue engineering to study host-pathogen interactions. Our intestinal 3D tissue model is built on a decellularized extracellular matrix scaffold, which is reseeded with human Caco-2 cells. Dynamic culture conditions enable the formation of a polarized mucosal epithelial barrier reminiscent of the 3D microarchitecture of the human small intestine. Infection with C. jejuni demonstrates that the 3D tissue model can reveal isolate-dependent colonization and barrier disruption phenotypes accompanied by perturbed localization of cell-cell junctions. Pathogenesis-related phenotypes of C. jejuni mutant strains in the 3D model deviated from those obtained with 2D-monolayers, but recapitulated phenotypes previously observed in animal models. Moreover, we demonstrate the involvement of a small regulatory RNA pair, CJnc180/190, during infections and observe different phenotypes of CJnc180/190 mutant strains in 2D vs. 3D infection models. Hereby, the CJnc190 sRNA exerts its pathogenic influence, at least in part, via repression of PtmG, which is involved in flagellin modification. Our results suggest that the Caco-2 cell-based 3D tissue model is a valuable and biologically relevant tool between in-vitro and in-vivo infection models to study virulence of C. jejuni and other gastrointestinal pathogens. KW - in vitro KW - stem cells KW - invasion KW - host KW - adhesion KW - epithelial cells KW - translocation KW - virulence KW - responses KW - microenvironment Y1 - 2020 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-229454 VL - 16 IS - 2 ER - TY - JOUR A1 - Solger, Franziska A1 - Kunz, Tobias C. A1 - Fink, Julian A1 - Paprotka, Kerstin A1 - Pfister, Pauline A1 - Hagen, Franziska A1 - Schumacher, Fabian A1 - Kleuser, Burkhard A1 - Seibel, Jürgen A1 - Rudel, Thomas T1 - A Role of Sphingosine in the Intracellular Survival of Neisseria gonorrhoeae JF - Frontiers in Cellular and Infection Microbiology N2 - Obligate human pathogenic Neisseria gonorrhoeae are the second most frequent bacterial cause of sexually transmitted diseases. These bacteria invade different mucosal tissues and occasionally disseminate into the bloodstream. Invasion into epithelial cells requires the activation of host cell receptors by the formation of ceramide-rich platforms. Here, we investigated the role of sphingosine in the invasion and intracellular survival of gonococci. Sphingosine exhibited an anti-gonococcal activity in vitro. We used specific sphingosine analogs and click chemistry to visualize sphingosine in infected cells. Sphingosine localized to the membrane of intracellular gonococci. Inhibitor studies and the application of a sphingosine derivative indicated that increased sphingosine levels reduced the intracellular survival of gonococci. We demonstrate here, that sphingosine can target intracellular bacteria and may therefore exert a direct bactericidal effect inside cells. KW - sphingosine KW - sphingolipids KW - sphingosine kinases KW - invasion KW - survival KW - click chemistry Y1 - 2020 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-204111 SN - 2235-2988 VL - 10 ER - TY - JOUR A1 - Schmidt, Marianne A1 - Skaf, Josef A1 - Gavril, Georgiana A1 - Polednik, Christine A1 - Roller, Jeanette A1 - Kessler, Michael A1 - Holzgrabe, Ulrike T1 - The influence of Osmunda regalis root extract on head and neck cancer cell proliferation, invasion and gene expression JF - BMC Complementary and Alternative Medicine N2 - Background: According to only a handful of historical sources, Osmunda regalis, the royal fern, has been used already in the middle age as an anti-cancer remedy. To examine this ancient cancer cure, an ethanolic extract of the roots was prepared and analysed in vitro on its effectiveness against head and neck cancer cell lines. Methods: Proliferation inhibition was measured with the MTT assay. Invasion inhibition was tested in a spheroid-based 3-D migration assay on different extracellular matrix surfaces. Corresponding changes in gene expression were analysed by qRT-PCR array. Induction of apoptosis was measured by fluorescence activated cell sorting (FACS) with the Annexin V binding method. The plant extract was analysed by preliminary phytochemical tests, liquid chromatography/mass spectroscopy (LC-MS) and thin layer chromatography (TLC). Anti-angiogenetic activity was determined by the tube formation assay. Results: O. regalis extract revealed a growth inhibiting effect on the head and neck carcinoma cell lines HLaC78 and FaDu. The toxic effect seems to be partially modulated by p-glycoprotein, as the MDR-1 expressing HLaC79-Tax cells were less sensitive. O. regalis extract inhibited the invasion of cell lines on diverse extracellular matrix substrates significantly. Especially the dispersion of the highly motile cell line HlaC78 on laminin was almost completely abrogated. Motility inhibition on laminin was accompanied by differential gene regulation of a variety of genes involved in cell adhesion and metastasis. Furthermore, O. regalis extract triggered apoptosis in HNSCC cell lines and inhibited tube formation of endothelial cells. Preliminary phytochemical analysis proved the presence of tannins, glycosides, steroids and saponins. Liquid chromatography/mass spectroscopy (LC-MS) revealed a major peak of an unknown substance with a molecular mass of 864.15 Da, comprising about 50% of the total extract. Thin layer chromatography identified ferulic acid to be present in the extract. Conclusion: The presented results justify the use of royal fern extracts as an anti-cancer remedy in history and imply a further analysis of ingredients. KW - head and neck carcinoma KW - invasion KW - plant extract KW - proliferation KW - HNSCC KW - metastasis KW - gene expression KW - Osmunda regalis Y1 - 2017 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-158704 VL - 17 IS - 518 ER - TY - THES A1 - Wolf, Katarina T1 - Migration of tumor cells and leukocytes in extracellular matrix : proteolytic and nonproteolytic strategies for overcoming tissue barriers T1 - Migration von Tumorzellen und Leukozyten in extrazellulärer Matrix : proteolytische und nicht-proteolytische Strategien zur Überwindung von Gewebsbarrieren N2 - The extracellular matrix within connective tissues represents a structural scaffold as well as a barrier for motile cells, such as invading tumor cells or passenger leukocytes. It remains unclear how different cell types utilize matrix-degrading enzymes for proteolytic migration strategies and, on the other hand, non-proteolytic strategies to overcome 3D fibrillar matrix networks. To monitor cell migration, a 3D collagen model in vitro or the mouse dermis in vivo were used, in combination with time-lapse video-, confocal- or intravital multiphoton-microscopy, and computer-assisted cell tracking. Expression of proteases, including several MMPs, ADAMs, serine proteases and cathepsins, was shown by flow cytometry, Western blot, zymography, and RT-PCR. Protease activity by migrating HT-1080 fibrosarcoma cells resulting in collagenolysis in situ and generation of tube-like matrix defects was detected by three newly developed techniques:(i) quantitative FITC-release from FITC-labelled collagen, (ii) structural alteration of the pyhsical matrix structure (macroscopically and microscopically), and (iii) the visualization of focal in situ cleavage of individual collagen fibers. The results show that highly invasive ollagenolytic cells utilized a spindle-shaped "mesenchymal" migration strategy, which involved beta1 integrindependent interaction with fibers, coclustering of beta1 integrins and matrix metalloproteinases (MMPs) at fiber bundling sites, and the proteolytic generation of a tube-like matrix-defect by MMPs and additional proteases. In contrast to tumor cells, activated T cells migrated through the collagen fiber network by flexible "amoeboid" crawling including a roundish, elliptoid shape and morphological adaptation along collagen fibers, which was independent of collagenase function and fiber degradation. Abrogation of collagenolysis in tumor cells was achieved by a cocktail of broad-spectrum protease inhibitors at non-toxic conditions blocking collagenolysis by up to 95%. While in T cells protease inhibition induced neither morphodynamic changes nor reduced migration rates, in tumor cells a time-dependent conversion was obtained from proteolytic mesenchymal to non-proteolytic amoeboid migration in collagen lattices in vitro as well as the mouse dermis in vivo monitored by intravital microscopy. Tumor cells vigorously squeezed through matrix gaps and formed constriction rings in regions of narrow space, while the matrix structure remained intact. MMPs were excluded from fiber binding sites and beta1 integrin distribution was non-clustered linear. Besides for fibrosarcoma cells, this mesenchymal-toameboid transition (MAT) was confirmed for epithelial MDA-MB-231 breast carcinoma cells. In conclusion, cells of different origin exhibit significant diversity as well as plasticity of protease function in migration. In tumor cells, MAT could respresent a functionally important cellular and molecular escape pathway in tumor invasion and migration. N2 - Die extrazelluläre Matrix (EZM) des Bindegewebes stellt sowohl ein strukturelles Gerüst als auch eine Barriere für migrierende Zellen dar, wie z.B. invadierende Tumorzellen oder zirkulierende Leukozyten. Es ist bisher unklar, wie diese verschiedenen Zelltypen matrix-degradierende Enzyme für eine proteolytische Migrationsstrategie benutzen bzw. ob und wie sie ohne deren Hilfe durch das Gewebe gelangen. Um Zellmigration in EZM zu untersuchen, wurde ein dreidimensionales Kollagenmodell in vitro wie auch Maus-Dermis in vivo eingesetzt und Zellmigration mittels Zeitraffer-Video-, Konfokal- und Multiphoton-Mikroskopie sowie computer-gestützter Zelltracking-Analyse dargestellt. Expression von Proteasen verschiedener Klassen, wie der MMPs, ADAMs, Serinproteasen und Cathepsine, wurde mittels Durchfluss-Zytometrie, Western blot, Zymographie oder RT-PCR detektiert. Gegen Kollagen gerichtete zelluläre Protease-Aktivität wurde mit Hilfe drei neu entwickelter Techniken dargestellt: (i)quantitative Messung von löslichem FITC aus FITC-markiertem fibrillären Kollagen, (ii) mikro-und makroskopische Reorganisation der physikalischen Matrix-Struktur, und (iii) Visualisierung der Topologie fokaler Degradation von Matrixfasern. Die Ergebnisse zeigen, dass hochinvasive spindelförmige HT-1080 Fibrosarkomzellen eine sogenannte "mesenchymale" Migrationsstrategie mit folgenden Charakteristika entwickelten: (i) beta1 Integrin-abhängige Interaktion mit Kollagenfasern, (ii) das "Co-clustering" von beta1 Integrinen und Matrix-Metalloproteinasen an Faserzugstellen und (iii) eine röhrenförmige, durch Proteasen verursachte Matrixdefektbildung. Im Gegensatz zu proteolytischen Tumorzellen migrierten T-Zellen rundlich-elliptoid mittels flexibler Morphodynamik, ähnlich wie Amöben, durch das Kollagennetzwerk und orientierten sich entlang Kollagenfasern, wobei sie keine biochemisch und strukturell detektierbare Faserdegradation zeigten. Um Tumorzell-vermittelte Kollagenolyse zu hemmen, wurde ein Cocktail, bestehend aus Breitspektrum-Protease-Inhibitioren, etabliert, der die Kollagenolyse unter nicht-toxischen Bedingungen um bis zu 98% blockierte. Während in T-Zellen keine morphodynamischen Veränderungen detektiert wurden, entwickelten Tumorzellen eine Verschiebung von proteolytisch mesenchymaler zu unverminderter nicht-proteolytisch amöboider Migration (mesenchymale-amöboide Transition - MAT) aus, sowohl in Kollagenmatrices in vitro als auch in Maus-Dermis in vivo, dargestellt mittels Intravital-Multiphoton-Mikroskopie. Die Tumorzellen "quetschten" sich dabei durch Lücken in der Matrix und bildeten sogenannte Konstriktionsringe aus, während die Matrixstruktur intakt blieb. MMPs lokalisierten nicht mehr an Faser-Kontakstellen auf der Zelloberfläche, und beta1 Integrine lagen nicht mehr geclustert vor. Neben HT-1080 Fibrosarkomzellen wurde MAT auch für MDA-MB-231 Brustkrebszellen epithelialer Herkunft nach Protease-Blockade detektiert. Somit entwickeln migrierende Zellen verschiedener Herkunft eine signifikante Diversität wie auch Plastizität bei der Migration durch EZM aus, resultierend aus der Funktionalität von Matrix-Proteasen. In Tumorzellen könnte MAT einen funktionell wichtigen zellulären und molekularen Anpassungsmechanismus für die Tumorinvasion und -migration darstellen. KW - Zellmigration KW - Grundsubstanz KW - Tumorzelle KW - Leukozyt KW - Zellmigration KW - Invasion KW - Karzinomzellen KW - Leukozyten KW - Matrixproteasen KW - Kollagenasen KW - Proteaseinhibitoren KW - cell migration KW - invasion KW - carcinoma cells KW - leukozytes KW - matrix proteases KW - collagenases KW - protease inhibitors Y1 - 2002 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-5670 ER - TY - THES A1 - Raffelsbauer, Diana T1 - Identification and characterization of the inlGHE gene cluster of Listeria monocytogenes T1 - Identifizierung und Charakterisierung des inlGHE-Genclusters von Listeria monocytogenes N2 - In the present study, a new gene cluster of Listeria monocytogenes EGD containing three internalin genes was identified and characterized. These genes, termed inlG, inlH and inlE, encode proteins of 490, 548 and 499 amino acids, respectively, which belong to the class of large, surface-bound internalins. Each of these proteins contains a signal peptide, two regions of repeats (Leucine-rich repeats and B repeats), an inter-repeat region and a putative cell wall anchor sequence containing the sorting motiv LPXTG. PCR analysis revealed the presence of the inlGHE gene cluster in most L. monocytogenes serotypes. A similar gene cluster termed inlC2DE localised to the same position on the chromosome was described in a different L. monocytogenes EGD isolate. Sequence comparison of the two clusters indicates that inlG is a new internalin gene, while inlH was generated by a site-specific recombination leading to an in-frame deletion which removed the 3'-terminal end of inlC2 and a 5'-portion of inlD. The genes inlG, inlH and inlE seem to be transcribed extracellularly and independent of PrfA. To study the function of the inlGHE gene cluster several in-frame deletion mutants were constructed which lack the genes of the inlGHE cluster individually or in combination with other inl genes. When tested in the mouse model, the inlGHE mutant showed a significant reduction of bacterial counts in liver and spleen in comparison to the wild type strain, indicating that the inlGHE gene cluster plays an important role in virulence of L. monocytogenes. The ability of this mutant to invade non-phagocytic cells in vitro was however two- to three-fold higher than that of the parental strain. To examine whether deletion of the single genes from the cluster has the same stimulatory effect on invasiveness as deletion of the complete gene cluster, the single in-frame deletion mutants inlG, inlH and inlE were constructed. These mutants were subsequently reverted to the wild type by introducing a copy of the corresponding intact gene into the chromosome by homologous recombination using knock-in plasmids. To determine a putative contribution of InlG, InlH and InlE in combination with other internalins to the entry of L. monocytogenes into mammalian cells, the combination mutants inlA/GHE, inlB/GHE, inlC/GHE, inlA/B/GHE, inlB/C/GHE, inlA/C and inlA/C/GHE were constructed. Transcription of the genes inlA, inlB and inlC in these mutants was studied by RT-PCR. Deletion of inlGHE enhances transcription of inlA and inlB, but not of inlC. This enhancement is not transient but can be observed at different time-points of the bacterial growth curve. Deletion of inlA also increases transcription of inlB and vice-versa. In contrast, the amounts of inlA and inlB transcripts in the single deletion mutants inlG, inlH and inlE were similar to those from the wild type. N2 - In der vorliegenden Arbeit wurde ein neues Gencluster von Listeria monocytogenes EGD mit drei Internalingenen identifiziert und charakterisiert. Diese als inlG, inlH und inlE bezeichneten Gene codieren für Proteine mit 490, 548 bzw. 499 Aminosäuren, die zur Klasse der großen, oberflächengebundenen Internaline gehören. Jedes dieser Proteine enthält ein Signalpeptid, zwei Repeat-Regionen (Leucin-reiche Repeats und B-Repeats), eine Inter-Repeat-Region, und eine mögliche Zellwandankersequenz mit dem Motiv LPXTG. PCR-Analyse zeigte das Vorkommen des inlGHE-Genclusters in den meisten L. monocytogenes-Serotypen. Ein ähnliches, als inlC2DE bezeichnetes Gencluster wurde in der gleichen Position auf dem Chromosom eines anderen L. monocytogenes EGD Isolats beschrieben. Ein Sequenzvergleich beider Clusters zeigte, dass inlG ein neues Internalingen ist, während inlH durch eine in-frame-Deletion vom 3'-Ende von inlC2 und einem 5'-Teil von inlD entstanden ist. Die Gene inlG, inlH und inlE werden vorwiegend extrazellulär und PrfA-unabhängig transkribiert. Um die Funktion des inlGHE-Genclusters zu untersuchen, wurden verschiedene in-frame-Deletionsmutanten hergestellt, aus denen die Gene des inlGHE-Clusters entweder einzeln oder in Kombination mit anderen Internalingenen deletiert wurden. Im Maumodell zeigte eine inlGHE-Mutante nach oraler Infektion eine signifikante Reduktion der Bakterienzahl in der Leber und Milz, die auf eine wichtige Rolle des inlGHE-Genclusters in der Virulenz von L. monocytogenes hindeutet. Die Fähigkeit dieser Mutante, in nicht-phagocytische Zellen in vitro einzudringen, ist zwei bis dreifach höher als die des Wildtyp-Stammes. Um zu untersuchen, ob die Deletion von Einzelgenen des inlGHE-Genclusters einen ähnlichen stimulatorischen Effekt auf die Invasivität ausübt wie die Deletion des kompletten Genclusters, wurden die Einzeldeletionsmutanten inlG, inlH and inlE hergestellt. Diese Mutanten wurden anschließend zum Wildtyp revertiert, indem eine Kopie des entsprechenden intakten Gens durch homologe Rekombination ins Chromosom mit Hilfe von Knock-in-Plasmiden eingeführt wurde. Um eine mögliche Rolle von InlG, InlH und InlE in Verbindung mit anderen Internalinen bei der Aufnahme von L. monocytogenes in Säugerzellen zu untersuchen, wurden die Mutanten inlA/GHE, inlB/GHE, inlC/GHE, inlA/B/GHE, inlB/C/GHE, inlA/C and inlA/C/GHE hergestellt. Die Transkription der Gene inlA, inlB and inlC in diesen Mutanten wurde durch RT-PCR untersucht. Deletion von inlGHE erhöht die Transkription von inlA und inlB, aber nicht die von inlC. Diese Erhöhung ist nicht vorübergehend sondern kann zu verschiedenen Zeitpunkten der Wachstumskurve beobachtet werden. Deletion von inlA verstärkt ebenfalls die Transcription von inlB und umgekehrt. Im Gegensatz dazu waren die Mengen an inlA- und inlB-Transkripten in den Einzeldeletionsmutanten inlG, inlH and inlE ähnlich wie die des Wildtyps. KW - Listeria monocytogenes KW - Molekulargenetik KW - Listeria monocytogenes KW - Virulenz KW - Internalin KW - inlGHE KW - Invasion KW - Leucin-reiche repeat protein KW - Listeria monocytogenes KW - virulence KW - internalin KW - inlGHE KW - invasion KW - leucine-rich repeat protein Y1 - 2001 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-1180595 ER -